Concepedia

Author

Kevin Imrie

Sunnybrook Health Science Centre

Also Known As

K Imrie, K R Imrie, K. Imrie, K. R. Imrie, Kevin Imrie, Kevin R Imrie, Kevin R. Imrie, Kevin Robert Imrie

131

Publications

6.2K

Citations

33

H-Index

88

Concepts

All Affiliations

Sunnybrook Health Science CentreUniversity of TorontoPrincess Margaret Cancer CentreHealth Sciences CentreSt. Michael's Hospital
KI

About

Kevin Imrie is an author at Sunnybrook Health Science Centre specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

17

2.8K

2

Health Sciences

6

6

238

3

Education

2

2

54

4

Management

1

1

11

5

Nursing

1

1

43

Kevin Imrie

×

42

Publications

5K

Citations

29

H-Index

YearCitations

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

Michael Pfreundschuh, Lorenz Trümper, Anders Österborg,

The Lancet Oncology

2006

2.1K

Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma

Robert Marcus, Kevin Imrie, Philippe Solal‐Céligny,

Journal of Clinical Oncology

2008

590

Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12

Michael Crump, John Kuruvilla, Stephen Couban,

Journal of Clinical Oncology

2014

454

Isolated Chloroma: The Effect of Early Antileukemic Therapy

Kevin Imrie

Annals of Internal Medicine

1995

215

Gemcitabine, dexamethasone and cisplatin is an active andnon-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group

Tara Baetz, Andrew R. Belch, Stephen Couban,

Annals of Oncology

2003

158

Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B‐cell non‐Hodgkin lymphoma

Michael Crump, Tara Baetz, Stephen Couban,

Cancer

2004

124

Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis

Joy Mangel, Heather A. Leitch, Joseph M. Connors,

Annals of Oncology

2004

99

Ovarian function after autologous bone marrow transplantation.

Aaron D. Schimmer, M Quatermain, Kevin Imrie,

Journal of Clinical Oncology

1998

86

Randomised controlled trial evaluating the effectiveness of behavioural interventions to modify cardiovascular risk factors in men and women with impaired glucose tolerance: outcomes at 6 months

John Oldroyd, Nigel Unwin, Martin White,

Diabetes Research and Clinical Practice

2001

76

Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections

H. Miles Prince, Kevin Imrie, D. Robert Sutherland,

British Journal of Haematology

1996

71

Page 1